azimilide has been researched along with Tachycardia, Ventricular in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 12 (80.00) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bharucha, DB; Dorian, P; Kowey, PR; Mahaffey, KW; Robinson, VM | 1 |
| Mitchell, LB | 1 |
| Khan, MH | 1 |
| Al-Khalidi, H; Brum, J; Henthorn, R; Holroyde, M; Niazi, I; Simmons, T; Singer, I; Tchou, P | 1 |
| Al-Khalidi, HR; Borggrefe, M; Brachmann, J; Brum, JM; Cannom, DS; Dorian, P; Hohnloser, SH; Holroyde, MJ; Myerburg, RJ; Pratt, CM; Singer, I; Tatla, DS; van der Laan, M | 1 |
| Hanna, IR; Langberg, JJ | 1 |
| Gerstenfeld, EP; Marchlinski, FE; Nayak, H; Patel, VV; Rajawat, YS | 1 |
| Al-Khalidi, HR; Borggrefe, M; Brachmann, J; Brum, JM; Cannom, DS; Dorian, P; Hohnloser, SH; Holroyde, MJ; Myerburg, RJ; Pratt, CM; Tatla, DS; van der Laan, M | 1 |
| Al-Khalidi, HR; Brum, JM; Dorian, P; Hohnloser, SH; Pratt, CM; Tatla, DS; Tchou, P | 1 |
| Kaźmierczak, J; Peregud-Pogorzelska, M; Rzeuski, R | 1 |
| Reiffel, JA | 1 |
| Black, SC; Butterfield, JL; Lucchesi, BR | 1 |
| Kowey, PR; Liu, T; Marinchak, RA; Wang, J; Wu, Y; Yan, GX | 1 |
| Cabo, C; Coromilas, JC; Schmitt, H; Wit, AL | 1 |
3 review(s) available for azimilide and Tachycardia, Ventricular
| Article | Year |
|---|---|
Role of drug therapy for sustained ventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Carbazoles; Carvedilol; Digoxin; Heart Conduction System; Humans; Hydantoins; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazolidines; Piperazines; Propanolamines; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Sotalol; Tachycardia, Ventricular | 2008 |
Oral class III antiarrhythmics: what is new?
Topics: Amiodarone; Anti-Arrhythmia Agents; Dronedarone; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sotalol; Sulfonamides; Tachycardia, Supraventricular; Tachycardia, Ventricular; Treatment Outcome | 2004 |
Adjunctive therapy for recurrent ventricular tachycardia in patients with implantable cardioverter defibrillators.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Combined Modality Therapy; Defibrillators, Implantable; Humans; Hydantoins; Imidazolidines; Piperazines; Secondary Prevention; Sotalol; Tachycardia, Ventricular; Treatment Outcome | 2007 |
4 trial(s) available for azimilide and Tachycardia, Ventricular
| Article | Year |
|---|---|
Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: The SHIELD-2 trial.
Topics: Aged; Anti-Arrhythmia Agents; Cardiovascular Diseases; Death, Sudden, Cardiac; Defibrillators, Implantable; Double-Blind Method; Early Termination of Clinical Trials; Electric Countershock; Emergency Service, Hospital; Female; Heart Failure; Hospitalization; Humans; Hydantoins; Male; Middle Aged; Odds Ratio; Piperazines; Proportional Hazards Models; Stroke Volume; Tachycardia, Ventricular; Ventricular Fibrillation | 2017 |
Azimilide decreases recurrent ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators.
Topics: Aged; Anti-Arrhythmia Agents; Defibrillators, Implantable; Double-Blind Method; Female; Humans; Hydantoins; Imidazoles; Imidazolidines; Male; Pilot Projects; Piperazines; Recurrence; Tachycardia, Ventricular | 2004 |
Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.
Topics: Anti-Arrhythmia Agents; Defibrillators, Implantable; Double-Blind Method; Electric Countershock; Endpoint Determination; Female; Humans; Hydantoins; Imidazolidines; Male; Middle Aged; Piperazines; Secondary Prevention; Tachycardia, Ventricular | 2004 |
Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial.
Topics: Anti-Arrhythmia Agents; Calcium Channel Blockers; Cohort Studies; Defibrillators, Implantable; Female; Humans; Hydantoins; Imidazolidines; Male; Middle Aged; Piperazines; Prospective Studies; Tachycardia, Ventricular; Treatment Outcome | 2006 |
8 other study(ies) available for azimilide and Tachycardia, Ventricular
| Article | Year |
|---|---|
The shocking story of azimilide.
Topics: Anti-Arrhythmia Agents; Defibrillators, Implantable; Electric Countershock; Humans; Hydantoins; Imidazolidines; Piperazines; Randomized Controlled Trials as Topic; Tachycardia, Ventricular | 2004 |
Advantages and pitfalls of combining device-based and pharmacologic therapies for the treatment of ventricular arrhythmias: observations from a tertiary referral center.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bradycardia; Combined Modality Therapy; Defibrillators, Implantable; Drug Interactions; Humans; Hydantoins; Imidazolidines; Pacemaker, Artificial; Piperazines; Sotalol; Tachycardia, Ventricular; Treatment Outcome | 2004 |
Design of the SHock Inhibition Evaluation with Azimilide (SHIELD) study: a novel method to assess antiarrhythmic drug effect in patients with an implantable cardioverter-defibrillator.
Topics: Anti-Arrhythmia Agents; Defibrillators, Implantable; Double-Blind Method; Drug Administration Schedule; Humans; Hydantoins; Imidazolidines; Piperazines; Randomized Controlled Trials as Topic; Research Design; Tachycardia, Ventricular; Treatment Outcome | 2005 |
QT Interval prolongation and torsades de pointes due to a coadministration of ciprofloxacin and azimilide in a patient with implantable cardioverter-defibrillator.
Topics: Aged; Anti-Arrhythmia Agents; Anti-Infective Agents; Ciprofloxacin; Defibrillators, Implantable; Drug Interactions; Electrocardiography; Female; Humans; Hydantoins; Imidazolidines; Long QT Syndrome; Piperazines; Tachycardia, Ventricular; Torsades de Pointes | 2007 |
Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug.
Topics: Animals; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Disease Models, Animal; Dogs; Electric Stimulation; Electrocardiography; Electrophysiology; Heart Rate; Hydantoins; Imidazoles; Imidazolidines; Male; Myocardial Infarction; Piperazines; Piperidines; Tachycardia, Ventricular; Ventricular Fibrillation | 1993 |
Electrophysiology test may predict SCD (sudden cardiac death) risk: investigators induce VT in CAD patients.
Topics: Anti-Arrhythmia Agents; Coronary Disease; Death, Sudden, Cardiac; Electrophysiology; Humans; Hydantoins; Imidazoles; Imidazolidines; Piperazines; Risk Assessment; Tachycardia, Ventricular; United States | 1999 |
Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome : direct evidence from intracellular recordings in the intact left ventricular wall.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiologic Techniques, Cardiac; Heart Conduction System; Heart Ventricles; Hydantoins; Imidazoles; Imidazolidines; In Vitro Techniques; Long QT Syndrome; Myocardial Contraction; Piperazines; Rabbits; Sotalol; Species Specificity; Systole; Tachycardia, Ventricular; Ventricular Dysfunction, Left | 2001 |
Effects of azimilide, a new class III antiarrhythmic drug, on reentrant circuits causing ventricular tachycardia and fibrillation in a canine model of myocardial infarction.
Topics: Animals; Anti-Arrhythmia Agents; Dogs; Drug Evaluation, Preclinical; Electrocardiography; Hydantoins; Imidazoles; Imidazolidines; Male; Models, Animal; Myocardial Infarction; Piperazines; Tachycardia, Ventricular; Ventricular Fibrillation | 2001 |